Patricia A. Loftus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Patricia A. Loftus has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Annick Aubin‐Pouliot
Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, CA
1 shared publicationEvan J. Patel
Department of Otolaryngology-Head & Neck Surgery, University of California, San Francisco
1 shared publication- Evan J. Patel
Department of Otolaryngology‐Head & Neck Surgery University of California San Francisco San Francisco California USA
1 shared publication Hailey M. Juszczak
School of Medicine, University of California, San Francisco, USA
1 shared publication- Hailey M. Juszczak
Department of Otolaryngology, SUNY Downstate Health Sciences University, Brooklyn, NY, United States
1 shared publication Jeffrey D. Sharon
Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, CA
1 shared publication
Latest Publications
- 9 February 2026
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 59 (3) , 509-518
Clinical Presentation and Epidemiology of Traumatic and Iatrogenic Cerebrospinal Fluid Leaks
- 9 February 2026
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 59 (3) , 509-518
Clinical Presentation and Epidemiology of Traumatic and Iatrogenic Cerebrospinal Fluid Leaks
- 29 August 2025
- Published by Springer Nature
- p. 175-184
Cryoablation and Radiofrequency Ablation of Posterior Nasal Nerve
- 29 August 2025
- Published by Springer Nature
- p. 175-184
Cryoablation and Radiofrequency Ablation of Posterior Nasal Nerve
- Open Access
- 15 March 2024
- Published by Elsevier in Otolaryngology Case Reports
- Vol. 31
Advanced nasopharyngeal angiofibroma in an adult resulting in an intracranial cyst
- 15 March 2024
- Published by Elsevier in Otolaryngology Case Reports
- Vol. 31
Open AccessAdvanced nasopharyngeal angiofibroma in an adult resulting in an intracranial cyst
- 9 July 2020
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 20 (10) , 1-10
Role of Allergy in Eustachian Tube Dysfunction
Purpose of Review Eustachian tube dysfunction (ETD) presents with symptoms of aural fullness and pressure, muffled hearing, tinnitus, and otalgia. When severe, it can lead to many common ear disorders such as otitis media with effusion, tympanic membrane retraction/perforation, and cholesteatoma. These diseases are prevalent in both the pediatric and adult population and significantly impact quality of life. The pathophysiology of ETD in the absence of an obstructive lesion has long been debated but is thought to be related to functional obstruction (i.e., inefficient tensor veli palatini muscle) and/or nasal cavity and nasopharyngeal inflammation. In the acute setting, the most common cause of nasal inflammation is an upper respiratory infection. When symptoms become chronic, however, the inflammation is thought to be associated with nasal irritants such as nasal allergens, i.e., allergic rhinitis (AR). The purpose of this review is to summarize our current understanding of the relationship between allergy and ETD. Recent Findings Past studies are either lacking or have reported equivocal findings regarding the relationship between allergy and ETD, and the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis has deemed the current level of evidence linking AR and ETD as low quality. A more recent study using a large adult population dataset did support an association between AR and ETD, but did not find that all cases of ETD are related to allergies. Furthermore, current evidence suggests that the use of medications that can decrease intranasal inflammation, such as intranasal corticosteroids or oral antihistamines, does not result in significant symptomatic improvement in patients with ETD. However, these studies included all patients with ETD, and evidence is lacking regarding the treatment effect of these medications on the subset of patients with concurrent AR and ETD. Summary Current best evidence does support an association between AR and ETD; however, not all patients with ETD suffer from AR, and vice versa. Further research is necessary to understand the mechanism behind this positive association and to elucidate the cause of chronic ETD in patients without associated allergies.
- 9 July 2020
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 20 (10) , 1-10
Role of Allergy in Eustachian Tube Dysfunction
Purpose of Review Eustachian tube dysfunction (ETD) presents with symptoms of aural fullness and pressure, muffled hearing, tinnitus, and otalgia. When severe, it can lead to many common ear disorders such as otitis media with effusion, tympanic membrane retraction/perforation, and cholesteatoma. These diseases are prevalent in both the pediatric and adult population and significantly impact quality of life. The pathophysiology of ETD in the absence of an obstructive lesion has long been debated but is thought to be related to functional obstruction (i.e., inefficient tensor veli palatini muscle) and/or nasal cavity and nasopharyngeal inflammation. In the acute setting, the most common cause of nasal inflammation is an upper respiratory infection. When symptoms become chronic, however, the inflammation is thought to be associated with nasal irritants such as nasal allergens, i.e., allergic rhinitis (AR). The purpose of this review is to summarize our current understanding of the relationship between allergy and ETD. Recent Findings Past studies are either lacking or have reported equivocal findings regarding the relationship between allergy and ETD, and the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis has deemed the current level of evidence linking AR and ETD as low quality. A more recent study using a large adult population dataset did support an association between AR and ETD, but did not find that all cases of ETD are related to allergies. Furthermore, current evidence suggests that the use of medications that can decrease intranasal inflammation, such as intranasal corticosteroids or oral antihistamines, does not result in significant symptomatic improvement in patients with ETD. However, these studies included all patients with ETD, and evidence is lacking regarding the treatment effect of these medications on the subset of patients with concurrent AR and ETD. Summary Current best evidence does support an association between AR and ETD; however, not all patients with ETD suffer from AR, and vice versa. Further research is necessary to understand the mechanism behind this positive association and to elucidate the cause of chronic ETD in patients without associated allergies.
- 15 January 2019
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 9 (5) , 466-472
Sinonasal risk factors for eustachian tube dysfunction: Cross‐sectional findings from NHANES 2011‐2012
Background: Sinonasal pathology is frequently cited as a cause of eustachian tube dysfunction (ETD), despite a lack of evidence. Using a large, nationally representative sample, we investigated whether abnormal tympanometry, an objective marker of ETD, was associated with infectious, allergic, and exposure‐related sinonasal risk factors.Methods: Relevant data were extracted from the 2011‐2012 National Health and Nutrition Examination Survey (NHANES). Tympanometric types (A, B, and C) were determined using peak pressure and compliance values. Participants with a type B or C tympanogram in at least one ear were classified as having ETD. Demographic and clinicopathologic risk factors with putative associations with ETD were determined. Statistical analysis, including regression modeling, was performed using Stata (version 15.1) to determine the correlation between sinonasal factors and ETD.Results: The final analysis included 1253 subjects and 19 variables. We controlled for demographic data including age, gender, race, and income. In both univariate and multivariate logistic regression, statistically significant correlations were found between abnormal tympanometric values and: (1) having a persistent cold/flu in the last 12 months (univariate: adjusted odds ratio [OR], 2.42; p = 0.006; multivariate: adjusted OR, 2.15; p = 0.006); and (2) experiencing “hay fever” (ie, allergic rhinitis) within the last 12 months (univariate: adjusted OR, 1.95; p = 0.021; multivariate: adjusted OR, 1.71; p = 0.039).Conclusion: Using a large, representative data set, we identified significant correlations between ETD and (1) persistent cold/flu symptoms and (2) self‐reported allergic rhinitis.
- 15 January 2019
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 9 (5) , 466-472
Sinonasal risk factors for eustachian tube dysfunction: Cross‐sectional findings from NHANES 2011‐2012
Background: Sinonasal pathology is frequently cited as a cause of eustachian tube dysfunction (ETD), despite a lack of evidence. Using a large, nationally representative sample, we investigated whether abnormal tympanometry, an objective marker of ETD, was associated with infectious, allergic, and exposure‐related sinonasal risk factors.Methods: Relevant data were extracted from the 2011‐2012 National Health and Nutrition Examination Survey (NHANES). Tympanometric types (A, B, and C) were determined using peak pressure and compliance values. Participants with a type B or C tympanogram in at least one ear were classified as having ETD. Demographic and clinicopathologic risk factors with putative associations with ETD were determined. Statistical analysis, including regression modeling, was performed using Stata (version 15.1) to determine the correlation between sinonasal factors and ETD.Results: The final analysis included 1253 subjects and 19 variables. We controlled for demographic data including age, gender, race, and income. In both univariate and multivariate logistic regression, statistically significant correlations were found between abnormal tympanometric values and: (1) having a persistent cold/flu in the last 12 months (univariate: adjusted odds ratio [OR], 2.42; p = 0.006; multivariate: adjusted OR, 2.15; p = 0.006); and (2) experiencing “hay fever” (ie, allergic rhinitis) within the last 12 months (univariate: adjusted OR, 1.95; p = 0.021; multivariate: adjusted OR, 1.71; p = 0.039).Conclusion: Using a large, representative data set, we identified significant correlations between ETD and (1) persistent cold/flu symptoms and (2) self‐reported allergic rhinitis.